HIF-1α is more dedicated to glycolysis, whose overactivation in tubular cells seem detrimental in CKD, whereas HIF-2α regulated EPO production and angiogenesis, crucial for renoprotection [43,44]. This evidence concerns the gene EPO and chronic kidney disease.